Cingulate Financial Statements From 2010 to 2025

CING Stock  USD 4.55  0.19  4.01%   
Cingulate financial statements provide useful quarterly and yearly information to potential Cingulate investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Cingulate financial statements helps investors assess Cingulate's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Cingulate's valuation are summarized below:
Gross Profit
-15.5 M
Market Capitalization
14.6 M
Earnings Share
(43.22)
There are over one hundred nineteen available fundamental signals for Cingulate, which can be analyzed over time and compared to other ratios. Active traders should verify all of Cingulate prevailing fundamental drivers against the trend between 2010 and 2025 to make sure the company can sustain itself down the road.
Check Cingulate financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cingulate's main balance sheet or income statement drivers, such as Depreciation And Amortization of 617.6 K, Interest Expense of 937 K or Selling General Administrative of 7.1 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Cingulate financial statements analysis is a perfect complement when working with Cingulate Valuation or Volatility modules.
  
Check out the analysis of Cingulate Correlation against competitors.
For more detail on how to invest in Cingulate Stock please use our How to Invest in Cingulate guide.

Cingulate Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3.8 MM6.5 M
Pretty Stable
Short and Long Term Debt TotalM3.6 M2.4 M
Slightly volatile
Other Current Liabilities1.2 M2.3 M646.7 K
Slightly volatile
Total Current Liabilities12.3 M11.8 M4.7 M
Slightly volatile
Net Tangible Assets2.4 M4.5 M1.6 M
Slightly volatile
Property Plant And Equipment NetM2.6 M3.9 M
Slightly volatile
Current Deferred Revenue858.3 K691.5 K613.1 K
Slightly volatile
Accounts Payable6.3 MM2.4 M
Slightly volatile
Cash57.3 K60.3 K1.7 M
Pretty Stable
Non Current Assets TotalM2.8 MM
Slightly volatile
Cash And Short Term Investments57.3 K60.3 K1.7 M
Pretty Stable
Net Receivables12.5 K13.2 K140.6 K
Very volatile
Common Stock Shares Outstanding64.5 K67.9 K682.1 K
Slightly volatile
Non Current Liabilities Total115.5 K121.6 K1.3 M
Slightly volatile
Capital Lease Obligations450 K473.7 K1.7 M
Slightly volatile
Other Current Assets1.2 M605.1 K688 K
Slightly volatile
Other Stockholder Equity57.9 M99 M26.2 M
Slightly volatile
Total Liabilities6.4 M11.9 M5.6 M
Slightly volatile
Net Invested Capital8.8 M10.2 M4.1 M
Slightly volatile
Property Plant And Equipment Gross5.7 M6.4 M4.9 M
Slightly volatile
Total Current Assets632.1 K665.4 K2.5 M
Pretty Stable
Accumulated Other Comprehensive Income13319081.4056
Slightly volatile
Capital Stock967K466 K
Slightly volatile
Short Term Debt2.1 M3.5 M1.2 M
Slightly volatile
Common Stock101106465.8 K
Slightly volatile
Property Plant Equipment3.1 M3.2 M3.9 M
Slightly volatile
Other Liabilities18.9 K21.3 K23.2 K
Slightly volatile
Short and Long Term DebtM5.8 M1.8 M
Slightly volatile
Non Current Liabilities Other18.9 K21.3 K23.2 K
Slightly volatile

Cingulate Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization617.6 K670.4 K356.8 K
Slightly volatile
Selling General Administrative7.1 M8.4 M4.3 M
Slightly volatile
Other Operating Expenses17.5 M26.2 M14.3 M
Slightly volatile
Research Development10.4 M17.8 M9.8 M
Slightly volatile
Cost Of Revenue667.6 K670.4 K373.9 K
Slightly volatile
Total Operating Expenses17.5 M26.2 M14.3 M
Slightly volatile
Reconciled Depreciation538.5 K575.4 K323.2 K
Slightly volatile

Cingulate Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow5.4 M6.2 M2.9 M
Slightly volatile
Depreciation556.6 K670.4 K335.5 K
Slightly volatile
Capital Expenditures192202720.6 K
Slightly volatile
Total Cash From Financing Activities12.2 M11.4 M8.4 M
Slightly volatile
End Period Cash Flow57.2760.281.7 M
Pretty Stable

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Average Payables495.9 K557.9 K608.3 K
Slightly volatile
Capex To Depreciation0.430.453.7619
Slightly volatile
Payables Turnover0.120.130.3775
Slightly volatile
Average Inventory51.2 K49.3 K49.7 K
Slightly volatile
Cash Per Share0.590.6336.4887
Pretty Stable
Days Payables Outstanding3.9 K3.7 K3.2 K
Slightly volatile
Income Quality604575114
Slightly volatile
Current Ratio0.04840.05091.3233
Pretty Stable
Graham Number1.1 K720704
Slightly volatile
Capex Per Share3.563.7415.9504
Slightly volatile
Interest Debt Per Share43.2237.446.8663
Pretty Stable
Debt To Assets0.850.810.462
Slightly volatile
Days Of Payables Outstanding3.9 K3.7 K3.2 K
Slightly volatile
Ebt Per Ebit0.810.930.982
Slightly volatile
Quick Ratio0.04960.05221.3226
Pretty Stable
Net Income Per E B T0.80.910.9786
Slightly volatile
Cash Ratio0.00440.00461.0355
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio0.00110.00120.8885
Slightly volatile
Debt Ratio0.850.810.462
Slightly volatile

Cingulate Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap25 M28.1 M30.6 M
Slightly volatile
Enterprise Value12.5 M14 M15.3 M
Slightly volatile

Cingulate Fundamental Market Drivers

Cash And Short Term Investments52.4 K

Cingulate Upcoming Events

8th of March 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
8th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Cingulate Financial Statements

Cingulate stakeholders use historical fundamental indicators, such as Cingulate's revenue or net income, to determine how well the company is positioned to perform in the future. Although Cingulate investors may analyze each financial statement separately, they are all interrelated. For example, changes in Cingulate's assets and liabilities are reflected in the revenues and expenses on Cingulate's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Cingulate. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue691.5 K858.3 K
Cost Of Revenue670.4 K667.6 K

Currently Active Assets on Macroaxis

When determining whether Cingulate is a strong investment it is important to analyze Cingulate's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cingulate's future performance. For an informed investment choice regarding Cingulate Stock, refer to the following important reports:
Check out the analysis of Cingulate Correlation against competitors.
For more detail on how to invest in Cingulate Stock please use our How to Invest in Cingulate guide.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cingulate. If investors know Cingulate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cingulate listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(43.22)
Return On Assets
(1.04)
Return On Equity
(2.74)
The market value of Cingulate is measured differently than its book value, which is the value of Cingulate that is recorded on the company's balance sheet. Investors also form their own opinion of Cingulate's value that differs from its market value or its book value, called intrinsic value, which is Cingulate's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cingulate's market value can be influenced by many factors that don't directly affect Cingulate's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cingulate's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cingulate is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cingulate's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.